![Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile]()
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profileZhao, Qingnan; Hu, Jiemiao; Mitra, Abhisek; Cutrera, Jeffry; Zhang, Wendong; Zhang, Zhongting; Yan, Jun; Xia, Xueqing; Mahadeo, Kris Michael; Livingston, John Andrew; Gorlick, Richard; Li, Shulin · Journal for ImmunoTherapy of Cancer · 2019